Technology area: Biotechnology & Pharmaceuticals
7 pending office actions • 7 art units • 7 examiners • 0 of 7 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
The Hospital for Sick Children has 7 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 7 distinct examiners and 7 distinct art units, showing complete distribution across the reported examination assignments. PATEL, JAY M is the busiest examiner, with 1 pending matter.
Because each pending matter has its own examiner and art unit, counsel should manage the docket on an application-by-application basis. A common scientific and claim framework can reduce inconsistency, but the distributed assignments make examiner-specific analysis essential. Portfolio oversight should emphasize deadline control, disclosure support, and careful tracking of how each art unit treats overlapping biotechnology concepts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (14%) |
| §112 only | 2 (29%) |
| Double-patenting + other | 2 (29%) |
| Multi-statute (no §101) | 2 (29%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PATEL, JAY M | 1 | 65.0% | +39.6% |
| COFFA, SERGIO | 1 | 61.1% | +32.3% |
| NICKOL, GARY B | 1 | 46.6% | +33.3% |
| CUNNINGCHEN, KATHLEEN MARY | 1 | 62.5% | +60.5% |
| PARK, EVELYN GRACE | 1 | 51.6% | +40.5% |
| XIAO, YAN | 1 | 67.3% | +52.7% |
| MEYERING, SHABANA SHABBEER | 1 | 68.5% | +45.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18800528 | SYSTEM AND METHOD FOR CANCER-CELL SPECIFIC TRANSCRIPTION IDENTIFICATION | PATEL, JAY M | — |
| 18371847 | APPARATUS FOR AUTOMATED PAIN TESTING IN RODENTS | PARK, EVELYN GRACE | — |
| 17598272 | COMPOSITIONS AND METHODS FOR TREATING CYSTIC FIBROSIS | MEYERING, SHABANA SHABBEER | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18800528 | SYSTEM AND METHOD FOR CANCER-CELL SPECIFIC TRANSCRIPTION IDENTIFICATION | PATEL, JAY M | — |
| 18703101 | RECOMBINANT POLYPEPTIDE FOR DISRUPTING INTERACTION OF EAG2 AND KVß2 AND THERAPEUTIC APPLICATIONS THEREOF IN CANCER TREATMENT | COFFA, SERGIO | — |
| 18701187 | MODIFIED MULTABODY CONSTRUCTS, COMPOSITIONS, AND METHODS TARGETING SARS-COV-2 | NICKOL, GARY B | — |
| 18685711 | MOLECULES THAT BIND TO PROTOGENIN (PRTG) POLYPEPTIDES | CUNNINGCHEN, KATHLEEN MARY | — |
| 18371847 | APPARATUS FOR AUTOMATED PAIN TESTING IN RODENTS | PARK, EVELYN GRACE | — |
| 18263217 | MULTABODY CONSTRUCTS, COMPOSITIONS, AND METHODS | XIAO, YAN | — |
| 17598272 | COMPOSITIONS AND METHODS FOR TREATING CYSTIC FIBROSIS | MEYERING, SHABANA SHABBEER | — |
| Art Unit | Apps |
|---|---|
| 3681 | 1 |
| 1658 | 1 |
| 1643 | 1 |
| 1646 | 1 |
| 3791 | 1 |
| 1642 | 1 |
| 1635 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18800528 | SYSTEM AND METHOD FOR CANCER-CELL SPECIFIC TRANSCRIPTION IDENTIFICATION | PATEL, JAY M | 3681 | §101DP | Non-Final OA | — | Pending | Aug 12, 2024 |
| 18703101 | RECOMBINANT POLYPEPTIDE FOR DISRUPTING INTERACTION OF EAG2 AND KVß2 AND THERAPEUTIC APPLICATIONS THEREOF IN CANCER TREATMENT | COFFA, SERGIO | 1658 | §112 | Final Rejection | — | Pending | Apr 19, 2024 |
| 18701187 | MODIFIED MULTABODY CONSTRUCTS, COMPOSITIONS, AND METHODS TARGETING SARS-COV-2 | NICKOL, GARY B | 1643 | §103§112DP | Non-Final OA | — | Pending | Apr 12, 2024 |
| 18685711 | MOLECULES THAT BIND TO PROTOGENIN (PRTG) POLYPEPTIDES | CUNNINGCHEN, KATHLEEN MARY | 1646 | §112 | Non-Final OA | — | Pending | Feb 22, 2024 |
| 18371847 | APPARATUS FOR AUTOMATED PAIN TESTING IN RODENTS | PARK, EVELYN GRACE | 3791 | §102§103 | Final Rejection | — | Pending | Sep 22, 2023 |
| 18263217 | MULTABODY CONSTRUCTS, COMPOSITIONS, AND METHODS | XIAO, YAN | 1642 | §102§103§112DP | Non-Final OA | — | Pending | Jul 27, 2023 |
| 17598272 | COMPOSITIONS AND METHODS FOR TREATING CYSTIC FIBROSIS | MEYERING, SHABANA SHABBEER | 1635 | §102§103 | Non-Final OA | — | Pending | Sep 26, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialThe Hospital for Sick Children has 7 pending office actions as of October 2026, spread across 7 art units and 7 examiners.
Jay M Patel has the most, with 1 of The Hospital for Sick Children's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
